Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Correction to: Translational Psychiatry 10.1038/s41398-022-01847-8, published online 14 March 2022

The original version of this article unfortunately contained mistakes. To ensure the accuracy of their article the authors would like to make the following corrections: Correction #1 Page 5, paragraph 1, line 5: Text currently reads “136”. This is incorrect and the authors are requesting to change it to “149”. Correction #2 Page 7, paragraph 4, line 17: Text currently reads “mild and moderately depressed patients”. This is incorrect and the authors are requesting to change it to: “patients with no or mild depression”. Correction #3 Supplementary Materials, Supplementary Table 2: The following Antipsychotic medications are incorrectly listed under Antidepressants: Olanzapine, Paliperidone, Perphenazine, Quetiapine, Risperidone, Thiothixene, Ziprasidone. The authors are requesting to update Supplementary Table 2 to include the above Antipsychotic medications in the Antipsychotic medication section of the table. The authors apologize for the errors. The original article has been corrected accordingly.